ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Preclinical DMPK Studies Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-0K17556
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Preclinical DMPK Studies Market Research Report 2024
BUY CHAPTERS

Global Preclinical DMPK Studies Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-0K17556
Report
November 2025
Pages:174
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Charles River
LabCorp
Eurofins Scientific
PPD
Inotiv, Inc.
ChemPartner
Evotec AG
Medicilon
Crown Bioscience
Jubilant Biosys
Creative-Biolabs
Allucent
Sai Life Sciences
Sygnature Discovery
Q2 Solutions
Invitrocue
Frontage
Bioduro-Sundia
WuXi AppTec
Pharmaron
Joinn Laboratories
Tigermed

Preclinical DMPK Studies Market

The global Preclinical DMPK Studies market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Drug metabolism and pharmacokinetics (DMPK) studies are a type of preclinical study that is used to assess the absorption, distribution, metabolism, and excretion (ADME) of a drug candidate. This information is essential for understanding how a drug will behave in the body and for designing safe and effective clinical trials.
DMPK studies can be performed in vitro or in vivo. In vitro DMPK studies are typically used to screen a large number of compounds for their ADME properties and to identify promising candidates for further development. In vivo DMPK studies are typically performed later in drug development, after a compound has been shown to have promising ADME properties in vitro.
From a downstream perspective, Pharmaceutical Companies accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Preclinical DMPK Studies leading manufacturers including Charles River, Labcorp, Eurofins Scientific, PPD, Inotiv, ChemPartner, Evotec, Medicilon, Crown Bioscience, Jubilant Biosys, etc., dominate supply; the top five capture approximately % of global revenue, with Charles River leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Preclinical DMPK Studies market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Preclinical DMPK Studies Market Report

Report Metric Details
Report Name Preclinical DMPK Studies Market
Segment by Type
  • In Vitro
  • In Vivo
Segment by Application
  • Pharmaceutical Companies
  • Medical Device Companies
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Labcorp, Eurofins Scientific, PPD, Inotiv, ChemPartner, Evotec, Medicilon, Crown Bioscience, Jubilant Biosys, Creative Biolabs, Allucent, Sai Life Sciences, Sygnature Discovery, Q2 Solutions, Invitrocue, Frontage, BioDuro-Sundia, Wuxi AppTec, Pharmaron, JOINN Laboratories, Tigermed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Preclinical DMPK Studies study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Preclinical DMPK Studies Market report?

Ans: The main players in the Preclinical DMPK Studies Market are Charles River, Labcorp, Eurofins Scientific, PPD, Inotiv, ChemPartner, Evotec, Medicilon, Crown Bioscience, Jubilant Biosys, Creative Biolabs, Allucent, Sai Life Sciences, Sygnature Discovery, Q2 Solutions, Invitrocue, Frontage, BioDuro-Sundia, Wuxi AppTec, Pharmaron, JOINN Laboratories, Tigermed

What are the Application segmentation covered in the Preclinical DMPK Studies Market report?

Ans: The Applications covered in the Preclinical DMPK Studies Market report are Pharmaceutical Companies, Medical Device Companies, Others

What are the Type segmentation covered in the Preclinical DMPK Studies Market report?

Ans: The Types covered in the Preclinical DMPK Studies Market report are In Vitro, In Vivo

1 Study Coverage
1.1 Introduction to Preclinical DMPK Studies: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Preclinical DMPK Studies Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 In Vitro
1.2.3 In Vivo
1.3 Market Segmentation by Application
1.3.1 Global Preclinical DMPK Studies Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Preclinical DMPK Studies Revenue Estimates and Forecasts 2020-2031
2.2 Global Preclinical DMPK Studies Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Preclinical DMPK Studies Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Preclinical DMPK Studies Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 In Vitro Market Size by Players
3.3.2 In Vivo Market Size by Players
3.4 Global Preclinical DMPK Studies Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Preclinical DMPK Studies Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Preclinical DMPK Studies Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Preclinical DMPK Studies Market Size by Type (2020-2031)
6.4 North America Preclinical DMPK Studies Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Preclinical DMPK Studies Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Preclinical DMPK Studies Market Size by Type (2020-2031)
7.4 Europe Preclinical DMPK Studies Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Preclinical DMPK Studies Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Preclinical DMPK Studies Market Size by Type (2020-2031)
8.4 Asia-Pacific Preclinical DMPK Studies Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Preclinical DMPK Studies Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Preclinical DMPK Studies Market Size by Type (2020-2031)
9.4 Central and South America Preclinical DMPK Studies Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Preclinical DMPK Studies Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Preclinical DMPK Studies Market Size by Type (2020-2031)
10.4 Middle East and Africa Preclinical DMPK Studies Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Preclinical DMPK Studies Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Business Overview
11.1.3 Charles River Preclinical DMPK Studies Product Features and Attributes
11.1.4 Charles River Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.1.5 Charles River Preclinical DMPK Studies Revenue by Product in 2024
11.1.6 Charles River Preclinical DMPK Studies Revenue by Application in 2024
11.1.7 Charles River Preclinical DMPK Studies Revenue by Geographic Area in 2024
11.1.8 Charles River Preclinical DMPK Studies SWOT Analysis
11.1.9 Charles River Recent Developments
11.2 Labcorp
11.2.1 Labcorp Corporation Information
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Preclinical DMPK Studies Product Features and Attributes
11.2.4 Labcorp Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.2.5 Labcorp Preclinical DMPK Studies Revenue by Product in 2024
11.2.6 Labcorp Preclinical DMPK Studies Revenue by Application in 2024
11.2.7 Labcorp Preclinical DMPK Studies Revenue by Geographic Area in 2024
11.2.8 Labcorp Preclinical DMPK Studies SWOT Analysis
11.2.9 Labcorp Recent Developments
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Corporation Information
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Preclinical DMPK Studies Product Features and Attributes
11.3.4 Eurofins Scientific Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.3.5 Eurofins Scientific Preclinical DMPK Studies Revenue by Product in 2024
11.3.6 Eurofins Scientific Preclinical DMPK Studies Revenue by Application in 2024
11.3.7 Eurofins Scientific Preclinical DMPK Studies Revenue by Geographic Area in 2024
11.3.8 Eurofins Scientific Preclinical DMPK Studies SWOT Analysis
11.3.9 Eurofins Scientific Recent Developments
11.4 PPD
11.4.1 PPD Corporation Information
11.4.2 PPD Business Overview
11.4.3 PPD Preclinical DMPK Studies Product Features and Attributes
11.4.4 PPD Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.4.5 PPD Preclinical DMPK Studies Revenue by Product in 2024
11.4.6 PPD Preclinical DMPK Studies Revenue by Application in 2024
11.4.7 PPD Preclinical DMPK Studies Revenue by Geographic Area in 2024
11.4.8 PPD Preclinical DMPK Studies SWOT Analysis
11.4.9 PPD Recent Developments
11.5 Inotiv
11.5.1 Inotiv Corporation Information
11.5.2 Inotiv Business Overview
11.5.3 Inotiv Preclinical DMPK Studies Product Features and Attributes
11.5.4 Inotiv Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.5.5 Inotiv Preclinical DMPK Studies Revenue by Product in 2024
11.5.6 Inotiv Preclinical DMPK Studies Revenue by Application in 2024
11.5.7 Inotiv Preclinical DMPK Studies Revenue by Geographic Area in 2024
11.5.8 Inotiv Preclinical DMPK Studies SWOT Analysis
11.5.9 Inotiv Recent Developments
11.6 ChemPartner
11.6.1 ChemPartner Corporation Information
11.6.2 ChemPartner Business Overview
11.6.3 ChemPartner Preclinical DMPK Studies Product Features and Attributes
11.6.4 ChemPartner Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.6.5 ChemPartner Recent Developments
11.7 Evotec
11.7.1 Evotec Corporation Information
11.7.2 Evotec Business Overview
11.7.3 Evotec Preclinical DMPK Studies Product Features and Attributes
11.7.4 Evotec Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.7.5 Evotec Recent Developments
11.8 Medicilon
11.8.1 Medicilon Corporation Information
11.8.2 Medicilon Business Overview
11.8.3 Medicilon Preclinical DMPK Studies Product Features and Attributes
11.8.4 Medicilon Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.8.5 Medicilon Recent Developments
11.9 Crown Bioscience
11.9.1 Crown Bioscience Corporation Information
11.9.2 Crown Bioscience Business Overview
11.9.3 Crown Bioscience Preclinical DMPK Studies Product Features and Attributes
11.9.4 Crown Bioscience Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.9.5 Crown Bioscience Recent Developments
11.10 Jubilant Biosys
11.10.1 Jubilant Biosys Corporation Information
11.10.2 Jubilant Biosys Business Overview
11.10.3 Jubilant Biosys Preclinical DMPK Studies Product Features and Attributes
11.10.4 Jubilant Biosys Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Creative Biolabs
11.11.1 Creative Biolabs Corporation Information
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs Preclinical DMPK Studies Product Features and Attributes
11.11.4 Creative Biolabs Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.11.5 Creative Biolabs Recent Developments
11.12 Allucent
11.12.1 Allucent Corporation Information
11.12.2 Allucent Business Overview
11.12.3 Allucent Preclinical DMPK Studies Product Features and Attributes
11.12.4 Allucent Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.12.5 Allucent Recent Developments
11.13 Sai Life Sciences
11.13.1 Sai Life Sciences Corporation Information
11.13.2 Sai Life Sciences Business Overview
11.13.3 Sai Life Sciences Preclinical DMPK Studies Product Features and Attributes
11.13.4 Sai Life Sciences Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.13.5 Sai Life Sciences Recent Developments
11.14 Sygnature Discovery
11.14.1 Sygnature Discovery Corporation Information
11.14.2 Sygnature Discovery Business Overview
11.14.3 Sygnature Discovery Preclinical DMPK Studies Product Features and Attributes
11.14.4 Sygnature Discovery Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.14.5 Sygnature Discovery Recent Developments
11.15 Q2 Solutions
11.15.1 Q2 Solutions Corporation Information
11.15.2 Q2 Solutions Business Overview
11.15.3 Q2 Solutions Preclinical DMPK Studies Product Features and Attributes
11.15.4 Q2 Solutions Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.15.5 Q2 Solutions Recent Developments
11.16 Invitrocue
11.16.1 Invitrocue Corporation Information
11.16.2 Invitrocue Business Overview
11.16.3 Invitrocue Preclinical DMPK Studies Product Features and Attributes
11.16.4 Invitrocue Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.16.5 Invitrocue Recent Developments
11.17 Frontage
11.17.1 Frontage Corporation Information
11.17.2 Frontage Business Overview
11.17.3 Frontage Preclinical DMPK Studies Product Features and Attributes
11.17.4 Frontage Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.17.5 Frontage Recent Developments
11.18 BioDuro-Sundia
11.18.1 BioDuro-Sundia Corporation Information
11.18.2 BioDuro-Sundia Business Overview
11.18.3 BioDuro-Sundia Preclinical DMPK Studies Product Features and Attributes
11.18.4 BioDuro-Sundia Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.18.5 BioDuro-Sundia Recent Developments
11.19 Wuxi AppTec
11.19.1 Wuxi AppTec Corporation Information
11.19.2 Wuxi AppTec Business Overview
11.19.3 Wuxi AppTec Preclinical DMPK Studies Product Features and Attributes
11.19.4 Wuxi AppTec Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.19.5 Wuxi AppTec Recent Developments
11.20 Pharmaron
11.20.1 Pharmaron Corporation Information
11.20.2 Pharmaron Business Overview
11.20.3 Pharmaron Preclinical DMPK Studies Product Features and Attributes
11.20.4 Pharmaron Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.20.5 Pharmaron Recent Developments
11.21 JOINN Laboratories
11.21.1 JOINN Laboratories Corporation Information
11.21.2 JOINN Laboratories Business Overview
11.21.3 JOINN Laboratories Preclinical DMPK Studies Product Features and Attributes
11.21.4 JOINN Laboratories Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.21.5 JOINN Laboratories Recent Developments
11.22 Tigermed
11.22.1 Tigermed Corporation Information
11.22.2 Tigermed Business Overview
11.22.3 Tigermed Preclinical DMPK Studies Product Features and Attributes
11.22.4 Tigermed Preclinical DMPK Studies Revenue and Gross Margin (2020-2025)
11.22.5 Tigermed Recent Developments
12 Preclinical DMPK StudiesIndustry Chain Analysis
12.1 Preclinical DMPK Studies Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Preclinical DMPK Studies Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Preclinical DMPK Studies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Charles River
LabCorp
Eurofins Scientific
PPD
Inotiv, Inc.
ChemPartner
Evotec AG
Medicilon
Crown Bioscience
Jubilant Biosys
Creative-Biolabs
Allucent
Sai Life Sciences
Sygnature Discovery
Q2 Solutions
Invitrocue
Frontage
Bioduro-Sundia
WuXi AppTec
Pharmaron
Joinn Laboratories
Tigermed
List of Tables
 Table 1. Global Preclinical DMPK Studies Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Preclinical DMPK Studies Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Preclinical DMPK Studies Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Preclinical DMPK Studies Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Preclinical DMPK Studies Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Preclinical DMPK Studies Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Preclinical DMPK Studies Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Preclinical DMPK Studies by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical DMPK Studies as of 2024)
 Table 11. Global Preclinical DMPK Studies Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Preclinical DMPK Studies Companies Headquarters
 Table 13. Global Preclinical DMPK Studies Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Preclinical DMPK Studies Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Preclinical DMPK Studies Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Preclinical DMPK Studies Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Preclinical DMPK Studies Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Preclinical DMPK Studies High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Preclinical DMPK Studies Growth Accelerators and Market Barriers
 Table 25. North America Preclinical DMPK Studies Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Preclinical DMPK Studies Growth Accelerators and Market Barriers
 Table 27. Europe Preclinical DMPK Studies Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Preclinical DMPK Studies Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Preclinical DMPK Studies Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Preclinical DMPK Studies Investment Opportunities and Key Challenges
 Table 31. Central and South America Preclinical DMPK Studies Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Preclinical DMPK Studies Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Preclinical DMPK Studies Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Charles River Corporation Information
 Table 35. Charles River Description and Major Businesses
 Table 36. Charles River Product Features and Attributes
 Table 37. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Charles River Revenue Proportion by Product in 2024
 Table 39. Charles River Revenue Proportion by Application in 2024
 Table 40. Charles River Revenue Proportion by Geographic Area in 2024
 Table 41. Charles River Preclinical DMPK Studies SWOT Analysis
 Table 42. Charles River Recent Developments
 Table 43. Labcorp Corporation Information
 Table 44. Labcorp Description and Major Businesses
 Table 45. Labcorp Product Features and Attributes
 Table 46. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Labcorp Revenue Proportion by Product in 2024
 Table 48. Labcorp Revenue Proportion by Application in 2024
 Table 49. Labcorp Revenue Proportion by Geographic Area in 2024
 Table 50. Labcorp Preclinical DMPK Studies SWOT Analysis
 Table 51. Labcorp Recent Developments
 Table 52. Eurofins Scientific Corporation Information
 Table 53. Eurofins Scientific Description and Major Businesses
 Table 54. Eurofins Scientific Product Features and Attributes
 Table 55. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Eurofins Scientific Revenue Proportion by Product in 2024
 Table 57. Eurofins Scientific Revenue Proportion by Application in 2024
 Table 58. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
 Table 59. Eurofins Scientific Preclinical DMPK Studies SWOT Analysis
 Table 60. Eurofins Scientific Recent Developments
 Table 61. PPD Corporation Information
 Table 62. PPD Description and Major Businesses
 Table 63. PPD Product Features and Attributes
 Table 64. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. PPD Revenue Proportion by Product in 2024
 Table 66. PPD Revenue Proportion by Application in 2024
 Table 67. PPD Revenue Proportion by Geographic Area in 2024
 Table 68. PPD Preclinical DMPK Studies SWOT Analysis
 Table 69. PPD Recent Developments
 Table 70. Inotiv Corporation Information
 Table 71. Inotiv Description and Major Businesses
 Table 72. Inotiv Product Features and Attributes
 Table 73. Inotiv Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Inotiv Revenue Proportion by Product in 2024
 Table 75. Inotiv Revenue Proportion by Application in 2024
 Table 76. Inotiv Revenue Proportion by Geographic Area in 2024
 Table 77. Inotiv Preclinical DMPK Studies SWOT Analysis
 Table 78. Inotiv Recent Developments
 Table 79. ChemPartner Corporation Information
 Table 80. ChemPartner Description and Major Businesses
 Table 81. ChemPartner Product Features and Attributes
 Table 82. ChemPartner Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. ChemPartner Recent Developments
 Table 84. Evotec Corporation Information
 Table 85. Evotec Description and Major Businesses
 Table 86. Evotec Product Features and Attributes
 Table 87. Evotec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Evotec Recent Developments
 Table 89. Medicilon Corporation Information
 Table 90. Medicilon Description and Major Businesses
 Table 91. Medicilon Product Features and Attributes
 Table 92. Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Medicilon Recent Developments
 Table 94. Crown Bioscience Corporation Information
 Table 95. Crown Bioscience Description and Major Businesses
 Table 96. Crown Bioscience Product Features and Attributes
 Table 97. Crown Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Crown Bioscience Recent Developments
 Table 99. Jubilant Biosys Corporation Information
 Table 100. Jubilant Biosys Description and Major Businesses
 Table 101. Jubilant Biosys Product Features and Attributes
 Table 102. Jubilant Biosys Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Jubilant Biosys Recent Developments
 Table 104. Creative Biolabs Corporation Information
 Table 105. Creative Biolabs Description and Major Businesses
 Table 106. Creative Biolabs Product Features and Attributes
 Table 107. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Creative Biolabs Recent Developments
 Table 109. Allucent Corporation Information
 Table 110. Allucent Description and Major Businesses
 Table 111. Allucent Product Features and Attributes
 Table 112. Allucent Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Allucent Recent Developments
 Table 114. Sai Life Sciences Corporation Information
 Table 115. Sai Life Sciences Description and Major Businesses
 Table 116. Sai Life Sciences Product Features and Attributes
 Table 117. Sai Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Sai Life Sciences Recent Developments
 Table 119. Sygnature Discovery Corporation Information
 Table 120. Sygnature Discovery Description and Major Businesses
 Table 121. Sygnature Discovery Product Features and Attributes
 Table 122. Sygnature Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Sygnature Discovery Recent Developments
 Table 124. Q2 Solutions Corporation Information
 Table 125. Q2 Solutions Description and Major Businesses
 Table 126. Q2 Solutions Product Features and Attributes
 Table 127. Q2 Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Q2 Solutions Recent Developments
 Table 129. Invitrocue Corporation Information
 Table 130. Invitrocue Description and Major Businesses
 Table 131. Invitrocue Product Features and Attributes
 Table 132. Invitrocue Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Invitrocue Recent Developments
 Table 134. Frontage Corporation Information
 Table 135. Frontage Description and Major Businesses
 Table 136. Frontage Product Features and Attributes
 Table 137. Frontage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Frontage Recent Developments
 Table 139. BioDuro-Sundia Corporation Information
 Table 140. BioDuro-Sundia Description and Major Businesses
 Table 141. BioDuro-Sundia Product Features and Attributes
 Table 142. BioDuro-Sundia Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. BioDuro-Sundia Recent Developments
 Table 144. Wuxi AppTec Corporation Information
 Table 145. Wuxi AppTec Description and Major Businesses
 Table 146. Wuxi AppTec Product Features and Attributes
 Table 147. Wuxi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. Wuxi AppTec Recent Developments
 Table 149. Pharmaron Corporation Information
 Table 150. Pharmaron Description and Major Businesses
 Table 151. Pharmaron Product Features and Attributes
 Table 152. Pharmaron Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. Pharmaron Recent Developments
 Table 154. JOINN Laboratories Corporation Information
 Table 155. JOINN Laboratories Description and Major Businesses
 Table 156. JOINN Laboratories Product Features and Attributes
 Table 157. JOINN Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. JOINN Laboratories Recent Developments
 Table 159. Tigermed Corporation Information
 Table 160. Tigermed Description and Major Businesses
 Table 161. Tigermed Product Features and Attributes
 Table 162. Tigermed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 163. Tigermed Recent Developments
 Table 164. Raw Materials Key Suppliers
 Table 165. Distributors List
 Table 166. Market Trends and Market Evolution
 Table 167. Market Drivers and Opportunities
 Table 168. Market Challenges, Risks, and Restraints
 Table 169. Research Programs/Design for This Report
 Table 170. Key Data Information from Secondary Sources
 Table 171. Key Data Information from Primary Sources


List of Figures
 Figure 1. Preclinical DMPK Studies Product Picture
 Figure 2. Global Preclinical DMPK Studies Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. In Vitro Product Picture
 Figure 4. In Vivo Product Picture
 Figure 5. Global Preclinical DMPK Studies Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Pharmaceutical Companies
 Figure 7. Medical Device Companies
 Figure 8. Others
 Figure 9. Preclinical DMPK Studies Report Years Considered
 Figure 10. Global Preclinical DMPK Studies Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Preclinical DMPK Studies Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Preclinical DMPK Studies Revenue Market Share by Region (2020-2031)
 Figure 14. Global Preclinical DMPK Studies Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. In Vitro Revenue Market Share by Player in 2024
 Figure 17. In Vivo Revenue Market Share by Player in 2024
 Figure 18. Global Preclinical DMPK Studies Revenue Market Share by Type (2020-2031)
 Figure 19. Global Preclinical DMPK Studies Revenue Market Share by Application (2020-2031)
 Figure 20. North America Preclinical DMPK Studies Revenue YoY (2020-2031) & (US$ Million)
 Figure 21. North America Top 5 Players Preclinical DMPK Studies Revenue (US$ Million) in 2024
 Figure 22. North America Preclinical DMPK Studies Revenue (US$ Million) by Type (2020 - 2031)
 Figure 23. North America Preclinical DMPK Studies Revenue (US$ Million) by Application (2020-2031)
 Figure 24. US Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 25. Canada Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 26. Mexico Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 27. Europe Preclinical DMPK Studies Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. Europe Top 5 Players Preclinical DMPK Studies Revenue (US$ Million) in 2024
 Figure 29. Europe Preclinical DMPK Studies Revenue (US$ Million) by Type (2020-2031)
 Figure 30. Europe Preclinical DMPK Studies Revenue (US$ Million) by Application (2020-2031)
 Figure 31. Germany Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 32. France Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 33. U.K. Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 34. Italy Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 35. Russia Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Preclinical DMPK Studies Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Top 8 Players Preclinical DMPK Studies Revenue (US$ Million) in 2024
 Figure 38. Asia-Pacific Preclinical DMPK Studies Revenue (US$ Million) by Type (2020-2031)
 Figure 39. Asia-Pacific Preclinical DMPK Studies Revenue (US$ Million) by Application (2020-2031)
 Figure 40. Indonesia Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 41. Japan Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 42. South Korea Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 43. Australia Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 44. India Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 45. Indonesia Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 46. Vietnam Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 47. Malaysia Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 48. Philippines Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 49. Singapore Preclinical DMPK Studies Revenue (2020-2031) & (US$ Million)
 Figure 50. Central and South America Preclinical DMPK Studies Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Central and South America Top 5 Players Preclinical DMPK Studies Revenue (US$ Million) in 2024
 Figure 52. Central and South America Preclinical DMPK Studies Revenue (US$ Million) by Type (2020-2031)
 Figure 53. Central and South America Preclinical DMPK Studies Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Brazil Preclinical DMPK Studies Revenue (2020-2025) & (US$ Million)
 Figure 55. Argentina Preclinical DMPK Studies Revenue (2020-2025) & (US$ Million)
 Figure 56. Middle East and Africa Preclinical DMPK Studies Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Middle East and Africa Top 5 Players Preclinical DMPK Studies Revenue (US$ Million) in 2024
 Figure 58. South America Preclinical DMPK Studies Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Middle East and Africa Preclinical DMPK Studies Revenue (US$ Million) by Application (2020-2031)
 Figure 60. GCC Countries Preclinical DMPK Studies Revenue (2020-2025) & (US$ Million)
 Figure 61. Israel Preclinical DMPK Studies Revenue (2020-2025) & (US$ Million)
 Figure 62. Egypt Preclinical DMPK Studies Revenue (2020-2025) & (US$ Million)
 Figure 63. South Africa Preclinical DMPK Studies Revenue (2020-2025) & (US$ Million)
 Figure 64. Preclinical DMPK Studies Industry Chain Mapping
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global ADME DMPK Studies Market Research Report 2024
Global Drug Metabolism and Pharmacokinetics DMPK Service Market Research Report 2024
Global Drug Metabolism and Pharmacokinetics DMPK Market Research Report 2024
Global DMPK Service Market Research Report 2024
Global PK PD Modeling Market Research Report 2024
In Vivo and In Vitro DMPK and ADME Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacokinetic Service Market Research Report 2025
Global In Vivo Pharmacology Service Market Research Report 2024
Global Pharmacokinetics Testing Service Market Research Report 2024
Global Metabolism Detection Kit Market Research Report 2024
Global Radiolabelled ADME Studies Market Research Report 2024
In Vitro ADME Services Market
Global Metabolism Assay Kit Market Research Report 2024
Global In Vivo and In Vitro ADME Market Research Report 2024
In Vivo and In Vitro ADME and PK Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacokinetic Research Market Research Report 2024
In Vitro ADME Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metabolomics Kit Market Research Report 2024
Global In Vivo Pharmacology Model Market Research Report 2024
Global In Vivo Pharmacology Market Research Report 2025

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions